Park Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$586K Buy
489
+8
+2% +$8.17K 0.35% 54
2026
Q1
$442K Sell
481
-3
-0.6% -$3.04K 0.43% 35
2025
Q4
$520K Buy
484
+4
+0.8% +$3.83K 0.37% 55
2025
Q3
$366K Buy
480
+11
+2% +$8.19K 0.29% 57
2025
Q2
$365K Buy
469
+10
+2% +$7.77K 0.34% 55
2025
Q1
$379K Buy
459
+32
+7% +$26.6K 0.44% 37
2024
Q4
$329K Buy
+427
New +$354K 0.39% 43

Other funds holding LLY

Park Capital Management's LLY Position: Q2 2026 in Review

Park Capital Management increased its Eli Lilly (LLY) stake by 1.7% in Q2 2026, buying an estimated $8.17K and bringing the position to 489 shares worth $586K. The position accounts for 0.35% of the portfolio, ranked #54.

Park Capital Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Park Capital Management held 489 shares of Eli Lilly worth $586K as of Q2 2026.
  • Park Capital Management bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
  • Eli Lilly made up 0.35% of Park Capital Management's portfolio in Q2 2026, its #54 holding.
  • Park Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Park Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.